Answers are grounded in this paper and cite their sources.
Shows that metabolic syndrome drives cartilage degeneration independently of body weight, highlighting chronic inflammation as a key therapeutic target.
In current scenario there is an emerging trend to consider osteoarthritis (OA) phenotypes based on their risk factors and therefore offering potential for targeted therapies. OA prevalence with other coexistence diseases, such as systemic arterial hypertension, cardiovascular disease, diabetes, and dyslipidemia are increasing. Majority of OA associated with MetS, despite overweight of patients, the occurrence of OA in joints do not bear load suggest, the chronic inflammation status existing in patients with MetS can alter the metabolism of cartilage, regardless of excessive weight. This paper indicates that factors responsible for metabolic syndrome has clear role in cartilage degeneration and further degradation.
No takes yet. Share an insight, caveat, or question.
Rishmeen Chadha (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: